Nippon Medical School Musashi Kosugi Hospital

Kawasaki 211-8533

2 studies enrolling now · 2 studies all time

What they study most

Amyloid, Cognitive Dysfunction, Diabetes Mellitus, Type 1, Lewy Body Disease, Synucleinopathies

Studies at this site

• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now